文献速递骨质疏松与代谢性骨病创伤骨科

临床骨折风险评估工具减少老年人未来骨质疏松性骨折的有效性和成本效益:一项结构化范围综述

The effectiveness and cost-effectiveness of clinical fracture-risk assessment tools in reducing future osteoporotic fractures among older adults: a structured scoping review.
PubMed 文献 · Osteoporos Int · 2023-01-04

该范围综述描述了临床骨折风险评估工具在老年人中预防未来骨质疏松性骨折的使用、有效性和成本效益。结果显示,筛查在预防所有骨质疏松相关骨折方面不优于常规护理,但积极影响参与者对骨质疏松的看法,可能减少髋部骨折,并似乎具有成本效益。

要点

  • 使用临床骨折风险评估工具筛查在预防所有骨质疏松相关骨折方面不优于常规护理。
  • 筛查可能降低髋部骨折风险,并对参与者骨质疏松看法有积极影响。
  • 多数模拟研究显示筛查具有显著潜在节省,可能具有成本效益。

核心结论

  • 根据现有证据,使用临床骨折风险评估筛查工具在预防所有骨质疏松相关骨折方面不优于常规护理。
  • 使用这些筛查工具积极影响女性对骨质疏松的看法,可能降低髋部骨折风险,并可能具有成本效益。
  • 这是一个相对较新的研究领域,需要更多研究。

研究设计与样本

  • 遵循Arksey和O'Malley及其修改版指南进行结构化范围综述。
  • 综合检索策略检索CINAHL、Medline和Embase数据库至2021年6月29日,无限制。
  • 筛选2484篇标题和68篇全文后纳入14项研究,并批判性评价所有纳入研究的质量。

主要发现

  • 四项随机对照试验调查临床骨折风险评估工具在老年女性中减少所有骨折的有效性,与常规护理相比未显示骨质疏松性骨折风险的统计学显著降低。
  • 其中两项试验的额外分析显示髋部骨折减少的趋势,结果可能具有临床意义。
  • 四项研究测试筛查项目对其他健康结局的影响,参与者报告积极结果。
  • 八项模拟研究估计使用这些工具筛查骨折的成本效益,大多数显示显著潜在节省。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 这是一个相对较新的研究领域,需要更多研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: This scoping review described the use, effectiveness, and cost-effectiveness of clinical fracture-risk assessment tools to prevent future osteoporotic fractures among older adults. Results show that the screening was not superior in preventing all osteoporosis-related fractures to usual care. However, it positively influenced participants' perspectives on osteoporosis, may have reduced hip fractures, and seemed cost-effective. PURPOSE: We aim to provide a synopsis of the evidence about the use of clinical fracture-risk assessment tools to influence health outcomes, including reducing future osteoporotic fractures and their cost-effectiveness. METHODS: We followed the guidelines of Arksey and O'Malley and their modifications. A comprehensive search strategy was created to search CINAHL, Medline, and Embase databases until June 29, 2021, with no restrictions. We critically appraised the quality of all included studies. RESULTS: Fourteen studies were included in the review after screening 2484 titles and 68 full-text articles. Four randomized controlled trials investigated the effectiveness of clinical fracture-risk assessment tools in reducing all fractures among older women. Using those assessment tools did not show a statistically significant reduction in osteoporotic fracture risk compared to usual care; however, additional analyses of two of these trials showed a trend toward reducing hip fractures, and the results might be clinically significant. Four studies tested the impact of screening programs on other health outcomes, and participants reported positive results. Eight simulation studies estimated the cost-effectiveness of using these tools to screen for fractures, with the majority showing significant potential savings. CONCLUSION: According to the available evidence to date, using clinical fracture-risk assessment screening tools was not more effective than usual care in preventing all osteoporosis-related fractures. However, using those screening tools positively influenced women's perspectives on osteoporosis, may have reduced hip fracture risk, and could potentially be cost-effective. This is a relatively new research area where additional studies are needed.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Auais M, Angermann H, Grubb M, et al. The effectiveness and cost-effectiveness of clinical fracture-risk assessment tools in reducing future osteoporotic fractures among older adults: a structured scoping review. Osteoporos Int. 2023. PMID: 36598523. doi:10.1007/s00198-022-06659-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。